Provided by Tiger Trade Technology Pte. Ltd.

Perspective Therapeutics

2.77
-0.2200-7.36%
Post-market: 2.820.0500+1.81%19:39 EDT
Volume:1.58M
Turnover:4.44M
Market Cap:315.78M
PE:-2.08
High:3.01
Open:2.96
Low:2.75
Close:2.99
52wk High:6.16
52wk Low:1.96
Shares:114.00M
Float Shares:67.88M
Volume Ratio:1.38
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3300
EPS(LYR):-1.3971
ROE:-39.57%
ROA:-22.28%
PB:0.98
PE(LYR):-1.98

Loading ...

LifeSci Capital Remains a Buy on Perspective Therapeutics (CATX)

TIPRANKS
·
May 16

Perspective Therapeutics price target lowered to $6 from $7 at BofA

TIPRANKS
·
May 13

Analysts Are Bullish on These Healthcare Stocks: SI-Bone (SIBN), Perspective Therapeutics (CATX)

TIPRANKS
·
May 12

Piper Sandler Remains a Buy on Perspective Therapeutics (CATX)

TIPRANKS
·
May 12

BTIG Remains a Buy on Perspective Therapeutics (CATX)

TIPRANKS
·
May 12

RBC Capital Sticks to Its Buy Rating for Perspective Therapeutics (CATX)

TIPRANKS
·
May 12

Perspective Therapeutics reports Q1 EPS (25c), consensus (30c)

TIPRANKS
·
May 12

Perspective Therapeutics Highlights Q1 Progress and Strengthened Finances

TIPRANKS
·
May 12

Perspective Therapeutics Q1 net loss widens as grant revenue drops

Reuters
·
May 12

Perspective Therapeutics Q1 EPS $(0.25) Beats $(0.31) Estimate, Sales $76.000K Miss $136.917K Estimate

Benzinga Earnings
·
May 12

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2026 Results

THOMSON REUTERS
·
May 12

Perspective Therapeutics Q1 EPS USD -0.25

THOMSON REUTERS
·
May 12

Perspective Therapeutics (CATX) Receives a Buy from JonesTrading

TIPRANKS
·
May 07

Perspective Therapeutics Price Target Maintained With a $11.00/Share by Wedbush

Dow Jones
·
May 05

RBC Capital Reaffirms Their Buy Rating on Perspective Therapeutics (CATX)

TIPRANKS
·
May 05

Perspective Therapeutics (CATX) Receives a Buy from Truist Financial

TIPRANKS
·
May 05

Perspective Therapeutics Highlights Alpha-Targeted Oncology Strategy Update

TIPRANKS
·
May 05

Perspective Therapeutics to host analyst event on strategy, enabling technology, pipeline

Reuters
·
Apr 24

Perspective Therapeutics to Provide Several Upcoming Corporate Updates

GlobeNewswire
·
Apr 24

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Centessa Pharmaceuticals (CNTA) and Perspective Therapeutics (CATX)

TIPRANKS
·
Apr 20